• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清可溶性CD40配体和白细胞介素-31与IgA肾病早期的关系

Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy.

作者信息

Tanaka Keiko, Sugiyama Hitoshi, Morinaga Hiroshi, Kitagawa Masashi, Kano Yuzuki, Onishi Yasuhiro, Mise Koki, Tanabe Katsuyuki, Uchida Haruhito A, Wada Jun

机构信息

Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Department of Medicine, Kawasaki Medical School General Medical Center and Department of Medical Care Work, Kawasaki College of Allied Health Professions, Okayama 700-8505, Japan.

出版信息

J Clin Med. 2023 Mar 3;12(5):2023. doi: 10.3390/jcm12052023.

DOI:10.3390/jcm12052023
PMID:36902810
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10004527/
Abstract

BACKGROUND

IgA nephropathy (IgAN) is a major cause of chronic glomerulonephritis worldwide. T cell dysregulation has been reported to contribute to the pathogenesis of IgAN. Methods We measured a broad range of Th1, Th2 and Th17 cytokines in the serum of IgAN patients. We searched for significant cytokines, which were associated with clinical parameters and histological scores in IgAN patients.

RESULTS

Among 15 cytokines, the levels of soluble CD40L (sCD40L) and IL-31 were higher in IgAN patients and were significantly associated with a higher estimated glomerular filtration rate (eGFR), a lower urinary protein to creatinine ratio (UPCR), and milder tubulointerstitial lesions (i.e., the early phase of IgAN). Multivariate analysis revealed that serum sCD40L was an independent determinant of a lower UPCR after adjustment for age, eGFR, and mean blood pressure (MBP). CD40, a receptor of sCD40L, has been reported to be upregulated on mesangial cells in IgAN. The sCD40L/CD40 interaction may directly induce inflammation in mesangial areas and may therefore be involved in the development of IgAN.

CONCLUSIONS

The present study demonstrated the significance of serum sCD40L and IL-31 in the early phase of IgAN. Serum sCD40L may be a marker of the beginning of inflammation in IgAN.

摘要

背景

IgA肾病(IgAN)是全球慢性肾小球肾炎的主要病因。据报道,T细胞失调参与了IgAN的发病机制。方法:我们检测了IgAN患者血清中多种Th1、Th2和Th17细胞因子。我们寻找与IgAN患者临床参数和组织学评分相关的显著细胞因子。

结果

在15种细胞因子中,IgAN患者血清中可溶性CD40L(sCD40L)和IL-31水平较高,且与较高的估计肾小球滤过率(eGFR)、较低的尿蛋白肌酐比值(UPCR)以及较轻的肾小管间质病变(即IgAN早期)显著相关。多变量分析显示,在调整年龄、eGFR和平均血压(MBP)后,血清sCD40L是UPCR降低的独立决定因素。sCD40L的受体CD40在IgAN的系膜细胞上已被报道上调。sCD40L/CD40相互作用可能直接诱导系膜区炎症,因此可能参与IgAN的发展。

结论

本研究证明了血清sCD40L和IL-31在IgAN早期的重要性。血清sCD40L可能是IgAN炎症开始的标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd7/10004527/19201cf28ade/jcm-12-02023-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd7/10004527/6ab16ae04863/jcm-12-02023-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd7/10004527/19201cf28ade/jcm-12-02023-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd7/10004527/6ab16ae04863/jcm-12-02023-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd7/10004527/19201cf28ade/jcm-12-02023-g002a.jpg

相似文献

1
Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy.血清可溶性CD40配体和白细胞介素-31与IgA肾病早期的关系
J Clin Med. 2023 Mar 3;12(5):2023. doi: 10.3390/jcm12052023.
2
Mechanism of Yiqi Yangying Heluo Formula in the Treatment of IgA Nephropathy by Affecting Gd-IgA1 Based on BAFF Molecular Level and T Lymphocyte Immunity.基于 BAFF 分子水平和 T 淋巴细胞免疫探讨益气养营河洛方治疗 IgA 肾病的作用机制。
Biomed Res Int. 2023 Jan 10;2023:5124034. doi: 10.1155/2023/5124034. eCollection 2023.
3
Imbalance of regulatory T cells to Th17 cells in IgA nephropathy.IgA 肾病中调节性 T 细胞与 Th17 细胞失衡。
Scand J Clin Lab Invest. 2012 May;72(3):221-9. doi: 10.3109/00365513.2011.652158. Epub 2012 Jan 25.
4
Comparison of clinical, pathological and long-term renal outcomes of children with Henoch-Schonlein purpura nephritis and IgA nephropathy.比较儿童过敏性紫癜肾炎和 IgA 肾病的临床、病理和长期肾脏结局。
Int Urol Nephrol. 2022 Aug;54(8):1925-1932. doi: 10.1007/s11255-021-03063-7. Epub 2021 Nov 30.
5
High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.高血清 IgA/C3 比值在蛋白尿≤1g/d 的原发性肾小球疾病患者中更能预测 IgA 肾病的诊断:一项观察性横断面研究。
BMC Nephrol. 2019 Apr 30;20(1):150. doi: 10.1186/s12882-019-1331-0.
6
Serum levels of tumor necrosis factor alpha in patients with IgA nephropathy are closely associated with disease severity.IgA 肾病患者的肿瘤坏死因子-α 血清水平与疾病严重程度密切相关。
BMC Nephrol. 2018 Nov 14;19(1):326. doi: 10.1186/s12882-018-1069-0.
7
Serum complement factor B is associated with disease activity and progression of idiopathic membranous nephropathy concomitant with IgA nephropathy.血清补体因子B与IgA肾病合并特发性膜性肾病的疾病活动及进展相关。
Int Urol Nephrol. 2022 Jun;54(6):1287-1294. doi: 10.1007/s11255-021-02997-2. Epub 2021 Sep 28.
8
MicroRNA-155-induced T lymphocyte subgroup drifting in IgA nephropathy.微小RNA-155诱导IgA肾病中T淋巴细胞亚群漂移
Int Urol Nephrol. 2017 Feb;49(2):353-361. doi: 10.1007/s11255-016-1444-3. Epub 2016 Oct 31.
9
Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.IgA 肾病患者中性粒细胞与淋巴细胞比值与肾小管萎缩/间质纤维化的关系。
J Clin Lab Anal. 2021 Jun;35(6):e23774. doi: 10.1002/jcla.23774. Epub 2021 May 5.
10
High Neutrophil-To-Lymphocyte Ratio Is an Independent Risk Factor for End Stage Renal Diseases in IgA Nephropathy.高中性粒细胞与淋巴细胞比值是 IgA 肾病终末期肾脏疾病的独立危险因素。
Front Immunol. 2021 Aug 12;12:700224. doi: 10.3389/fimmu.2021.700224. eCollection 2021.

引用本文的文献

1
Drugs in Development to Treat IgA Nephropathy.治疗 IgA 肾病的在研药物。
Drugs. 2024 May;84(5):503-525. doi: 10.1007/s40265-024-02036-1. Epub 2024 May 23.

本文引用的文献

1
Interleukin-31 and soluble CD40L: new candidate serum biomarkers that predict therapeutic response in multiple sclerosis.白细胞介素-31 和可溶性 CD40L:预测多发性硬化症治疗反应的新候选血清生物标志物。
Neurol Sci. 2022 Nov;43(11):6271-6278. doi: 10.1007/s10072-022-06276-5. Epub 2022 Jul 18.
2
CD40/CD40L Signaling as a Promising Therapeutic Target for the Treatment of Renal Disease.CD40/CD40L信号通路作为治疗肾脏疾病的一个有前景的治疗靶点
J Clin Med. 2020 Nov 13;9(11):3653. doi: 10.3390/jcm9113653.
3
T lymphocytes in IgA nephropathy.IgA肾病中的T淋巴细胞。
Exp Ther Med. 2020 Jul;20(1):186-194. doi: 10.3892/etm.2020.8673. Epub 2020 Apr 22.
4
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy.评估 IgA 肾病的新型国际风险预测工具。
JAMA Intern Med. 2019 Jul 1;179(7):942-952. doi: 10.1001/jamainternmed.2019.0600.
5
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.IgA 肾病的病理评分是否具有长期价值?牛津 IgA 肾病分类(VALIGA)更新的验证研究。
Nephrol Dial Transplant. 2020 Jun 1;35(6):1002-1009. doi: 10.1093/ndt/gfy302.
6
T cells in IgA nephropathy: role in pathogenesis, clinical significance and potential therapeutic target.IgA肾病中的T细胞:在发病机制中的作用、临床意义及潜在治疗靶点
Clin Exp Nephrol. 2019 Mar;23(3):291-303. doi: 10.1007/s10157-018-1665-0. Epub 2018 Nov 7.
7
Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS.可溶性CD40配体可直接改变肾小球通透性,并可能在局灶节段性肾小球硬化中作为一种循环通透性因子发挥作用。
PLoS One. 2017 Nov 20;12(11):e0188045. doi: 10.1371/journal.pone.0188045. eCollection 2017.
8
Decreased serum levels of sCD40L and IL-31 correlate in treated patients with Relapsing-Remitting Multiple Sclerosis.复发缓解型多发性硬化症患者经治疗后,血清可溶性CD40配体(sCD40L)水平和白细胞介素-31(IL-31)水平降低具有相关性。
Immunobiology. 2018 Jan;223(1):135-141. doi: 10.1016/j.imbio.2017.10.001. Epub 2017 Oct 5.
9
Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.口服甲泼尼龙对IgA肾病患者临床结局的影响:TESTING随机临床试验
JAMA. 2017 Aug 1;318(5):432-442. doi: 10.1001/jama.2017.9362.
10
New insights into the pathogenesis of IgA nephropathy.IgA 肾病发病机制的新见解。
Pediatr Nephrol. 2018 May;33(5):763-777. doi: 10.1007/s00467-017-3699-z. Epub 2017 Jun 17.